LIDDS AB (publ) (LIDDS.ST)

SEK 0.11

(-3.65%)

Eps Summary of LIDDS AB (publ)

  • LIDDS AB (publ)'s latest annual eps in 2023 was -0.63 SEK , up 37.0% from previous year.
  • LIDDS AB (publ)'s latest quarterly eps in 2024 Q2 was -0.02 SEK , down 0.0% from previous quarter.
  • LIDDS AB (publ) reported an annual eps of -1.00 SEK in 2022, up 7.41% from previous year.
  • LIDDS AB (publ) reported an annual eps of -1.08 SEK in 2021, up 3.57% from previous year.
  • LIDDS AB (publ) reported a quarterly eps of - SEK for 2024 Q1, up 100.0% from previous quarter.
  • LIDDS AB (publ) reported a quarterly eps of -0.18 SEK for 2023 Q1, up 28.0% from previous quarter.

Annual Eps Chart of LIDDS AB (publ) (2023 - 2010)

Historical Annual Eps of LIDDS AB (publ) (2023 - 2010)

Year Eps Eps Growth
2023 -0.63 SEK 37.0%
2022 -1.00 SEK 7.41%
2021 -1.08 SEK 3.57%
2020 -1.12 SEK -20.43%
2019 -0.93 SEK -481.25%
2018 -0.16 SEK 50.0%
2017 -0.32 SEK 8.57%
2016 -0.35 SEK 36.36%
2015 -0.55 SEK -10.0%
2014 -0.50 SEK -35.14%
2013 -0.37 SEK 0.0%
2012 -0.37 SEK -5.71%
2011 -0.35 SEK -105.88%
2010 -0.17 SEK 0.0%

Peer Eps Comparison of LIDDS AB (publ)

Name Eps Eps Difference
Alligator Bioscience AB (publ) -0.55 SEK -14.545%
Ziccum AB (publ) -1.54 SEK 59.091%
Modus Therapeutics Holding AB (publ) -1.01 SEK 37.624%
BioArctic AB (publ) 2.60 SEK 124.231%
Sprint Bioscience AB (publ) -0.01 SEK -9900.0%
Mendus AB (publ) -4.40 SEK 85.682%
Genovis AB (publ.) 0.94 SEK 167.021%
Intervacc AB (publ) -1.69 SEK 62.722%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK -186.364%
Active Biotech AB (publ) -0.17 SEK -270.588%
Magle Chemoswed Holding AB (publ) 1.13 SEK 155.752%
Bio-Works Technologies AB (publ) -1.57 SEK 59.873%
Aptahem AB (publ) -0.05 SEK -1204.348%
Vicore Pharma Holding AB (publ) -3.22 SEK 80.435%
Kancera AB (publ) -0.80 SEK 21.25%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 93.668%
Fluicell AB (publ) -0.24 SEK -162.5%
Saniona AB (publ) -1.29 SEK 51.163%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK -231.579%
Biovica International AB (publ) -2.14 SEK 70.561%
Spago Nanomedical AB (publ) -0.43 SEK -46.512%
AcouSort AB (publ) -1.29 SEK 51.163%
Xintela AB (publ) -0.13 SEK -384.615%
Abliva AB (publ) -0.09 SEK -596.903%
Egetis Therapeutics AB (publ) -1.27 SEK 50.394%
Karolinska Development AB (publ) 0.02 SEK 3250.0%
OncoZenge AB (publ) -1.36 SEK 53.676%
Amniotics AB (publ) -0.01 SEK -5627.273%
2cureX AB (publ) -1.85 SEK 65.946%
CombiGene AB (publ) -1.80 SEK 65.0%
Asarina Pharma AB (publ) -0.57 SEK -10.526%
Calliditas Therapeutics AB (publ) -8.69 SEK 92.75%
Camurus AB (publ) 7.78 SEK 108.098%
Corline Biomedical AB -0.08 SEK -648.219%
IRLAB Therapeutics AB (publ) -3.43 SEK 81.633%
Isofol Medical AB (publ) -0.23 SEK -173.913%
I-Tech AB 1.70 SEK 137.059%
Hansa Biopharma AB (publ) -15.83 SEK 96.02%
Cyxone AB (publ) -0.22 SEK -186.364%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 68.182%
Biosergen AB -0.60 SEK -5.0%
Cantargia AB (publ) -1.65 SEK 61.818%
NextCell Pharma AB -1.03 SEK 38.835%
Xspray Pharma AB (publ) -6.76 SEK 90.68%
Elicera Therapeutics AB (publ) -0.83 SEK 24.096%
Nanologica AB (publ) -2.05 SEK 69.268%
SynAct Pharma AB -6.64 SEK 90.512%
Annexin Pharmaceuticals AB (publ) -0.26 SEK -142.308%
Stayble Therapeutics AB (publ) -0.92 SEK 31.522%
Lipum AB (publ) -4.45 SEK 85.843%
BioInvent International AB (publ) -5.02 SEK 87.45%
Alzinova AB (publ) -0.41 SEK -53.659%
Oncopeptides AB (publ) -1.96 SEK 67.857%
Pila Pharma AB (publ) -0.47 SEK -34.043%
Guard Therapeutics International AB (publ) -11.26 SEK 94.405%
Scandinavian ChemoTech AB (publ) -1.13 SEK 44.248%
Simris Alg AB (publ) -0.16 SEK -293.75%
Diamyd Medical AB (publ) -1.60 SEK 60.625%
Xbrane Biopharma AB (publ) -1.27 SEK 50.394%
Ascelia Pharma AB (publ) -3.24 SEK 80.556%
Diagonal Bio AB (publ) -0.32 SEK -96.875%